Literature DB >> 21487252

Ignoring the group in group-level HIV/AIDS intervention trials: a review of reported design and analytic methods.

Sherri L Pals1, Ryan E Wiegand, David M Murray.   

Abstract

OBJECTIVES: Studies evaluating the efficacy of HIV/AIDS interventions often involve the random assignment of groups of participants or the treatment of participants in groups. These studies require analytic methods that take within-group correlation into account. We reviewed published studies to determine the extent to which within-group correlation was dealt with properly.
DESIGN: We reviewed group-randomized trials (GRTs) and individually randomized group treatment (IRGT) trials published in HIV/AIDS and general public health journals 2005-2009.
METHODS: At least two of the authors reviewed each article, recording descriptive characteristics, sample size estimation methods, analytic methods, and judgments about whether the methods took intraclass correlation into account properly.
RESULTS: Of those articles including sufficient information to judge whether analytic methods were correct, only 24% used only appropriate methods for dealing with the intraclass correlation. The percentages differed substantially for GRTs (41.7%) and IRGT trials (8.0%). Most of the articles (69.2%) also made no mention of a priori sample size estimation.
CONCLUSION: A majority of the articles in our review reported analyses ignoring the intraclass correlation. This practice may result in underestimated variance, inappropriately small P values, and incorrect conclusions about the effectiveness of interventions. Previous trials that were analyzed incorrectly need to be re-analyzed, and future trials should be designed and analyzed with appropriate methods. Also, journal reviewers and editors need to be aware of the special requirements for design and analysis of GRTs and IRGT trials and judge the quality of articles reporting on such trials according to appropriate standards.

Entities:  

Mesh:

Year:  2011        PMID: 21487252     DOI: 10.1097/QAD.0b013e3283467198

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

Review 1.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

2.  Reductions in traumatic stress following a coping intervention were mediated by decreases in avoidant coping for people living with HIV/AIDS and childhood sexual abuse.

Authors:  Kathleen J Sikkema; Krista W Ranby; Christina S Meade; Nathan B Hansen; Patrick A Wilson; Arlene Kochman
Journal:  J Consult Clin Psychol       Date:  2012-10-01

3.  Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups.

Authors:  Rebecca R Andridge; Abigail B Shoben; Keith E Muller; David M Murray
Journal:  Stat Med       Date:  2014-01-08       Impact factor: 2.373

4.  Influential methods reports for group-randomized trials and related designs.

Authors:  David M Murray
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.599

5.  Parameters for sample size estimation from a group-randomized HIV prevention trial in HIV clinics in sub-Saharan Africa.

Authors:  Jun Zhang; Sherri L Pals; Amy Medley; Catherine Nichols; Pam Bachanas; Deon van Zyl; Frieda Katuta; James Juma
Journal:  AIDS Behav       Date:  2014-12

6.  Evaluation of two implementation strategies in 51 child county public service systems in two states: results of a cluster randomized head-to-head implementation trial.

Authors:  C Hendricks Brown; Patricia Chamberlain; Lisa Saldana; Courtenay Padgett; Wei Wang; Gracelyn Cruden
Journal:  Implement Sci       Date:  2014-10-14       Impact factor: 7.327

7.  Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania.

Authors:  Dale Barnhart; Ellen Hertzmark; Enju Liu; Ester Mungure; Aisa N Muya; David Sando; Guerino Chalamilla; Nzovu Ulenga; Till Bärnighausen; Wafaie Fawzi; Donna Spiegelman
Journal:  Contemp Clin Trials Commun       Date:  2016-09-14

8.  Statistical design and analysis plan for an impact evaluation of an HIV treatment and prevention intervention for female sex workers in Zimbabwe: a study protocol for a cluster randomised controlled trial.

Authors:  James R Hargreaves; Elizabeth Fearon; Calum Davey; Andrew Phillips; Valentina Cambiano; Frances M Cowan
Journal:  Trials       Date:  2016-01-05       Impact factor: 2.279

9.  Evaluation of the Potential Risk of Mortality from SARS-CoV-2 Infection in Hospitalized Patients According to the Charlson Comorbidity Index.

Authors:  Jose Roberto Gutierrez-Camacho; Lorena Avila-Carrasco; Alberto Murillo-Ruíz-Esparza; Idalia Garza-Veloz; Roxana Araujo-Espino; Maria Calixta Martinez-Vazquez; Perla M Trejo-Ortiz; Iram Pablo Rodriguez-Sanchez; Iván Delgado-Enciso; Maria E Castañeda-López; Araceli Gamón-Madrid; Margarita L Martinez-Fierro
Journal:  Healthcare (Basel)       Date:  2022-02-12

10.  Accounting for Context in Randomized Trials after Assignment.

Authors:  C Hendricks Brown; Donald Hedeker; Robert D Gibbons; Naihua Duan; Daniel Almirall; Carlos Gallo; Inger Burnett-Zeigler; Guillermo Prado; Sean D Young; Alberto Valido; Peter A Wyman
Journal:  Prev Sci       Date:  2022-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.